Less Daily Movement Linked to Faster MS Progression & Brain Shrinkage
Subtle shifts in daily activity, particularly a decrease in movement in the mornings, may serve as an early warning sign of multiple sclerosis (MS) progression, according to a recent study published in Neurology. Researchers found a correlation between changes in activity patterns tracked by wearable sensors and both brain tissue loss and worsening disability in individuals with MS. This suggests that continuous monitoring with readily available devices could potentially detect disease progression earlier than traditional clinical assessments allow.
Wearable Sensors and the Detection of Subtle Changes
The study, titled “Association of Changes in Activity Patterns With Brain Atrophy and Disability Progression in People With Multiple Sclerosis,” involved a cohort of individuals already diagnosed with MS. Participants wore wrist-worn activity trackers, and the data collected was analyzed alongside MRI scans to measure brain atrophy and assessments of disability progression. The findings highlighted that reductions in activity levels, especially noticeable in the morning, were associated with increased rates of brain shrinkage and a decline in physical function.
Ellen Mowry, MD, lead author of the study and a neurologist at Johns Hopkins School of Medicine, emphasized the potential of this approach. “More research is needed to confirm these findings, but it’s exciting to think that using easily accessible devices could support us predict who is at risk of worsening disease and potentially prevent those changes,” she stated in a press release from the American Academy of Neurology (AAN). As reported by Multiple Sclerosis News Today, Dr. Mowry also noted that detecting these small changes could accelerate research into new treatments.
Understanding Multiple Sclerosis
Multiple sclerosis is a chronic, often debilitating disease that affects the central nervous system – the brain and spinal cord. It’s an autoimmune condition, meaning the body’s immune system mistakenly attacks its own tissues. In MS, the immune system damages the myelin sheath, a protective covering around nerve fibers. This damage disrupts communication between the brain and the rest of the body, leading to a wide range of symptoms, including fatigue, difficulty walking, numbness, and vision problems. The severity and specific symptoms of MS vary greatly from person to person.
Beyond Activity Trackers: Exploring Wearable Brain Imaging
The use of wearable technology in MS research extends beyond activity trackers. Researchers at the University of Nottingham are pioneering the use of a lightweight, wearable magnetoencephalography (OPM-MEG) brain scanner. As detailed in Open Access Government, this technology allows for real-time monitoring of brain function during natural movements and everyday activities, unlike traditional MRI scans which primarily map brain structure. The OPM-MEG scanner has revealed distinct changes in brain function in people with MS, including altered neural communication and slower responses in motor areas. This non-invasive approach offers promising avenues for improved diagnosis and tracking of disease progression.
How Wearable Technology Measures Activity
Wrist-worn activity trackers, like those used in the recent study, typically measure several key metrics, including step count, distance traveled, and periods of inactivity. More advanced trackers can also monitor heart rate and sleep patterns. By analyzing these data points, researchers can gain insights into an individual’s overall activity levels and identify subtle changes that might indicate a decline in physical function. The advantage of continuous monitoring is that it captures a more comprehensive picture of a person’s daily activity than periodic assessments in a clinical setting.
The Importance of Early Detection and What the Study Doesn’t Tell Us
Early detection of MS progression is crucial for several reasons. It allows clinicians to adjust treatment plans more proactively, potentially slowing down the disease’s advancement and preserving neurological function. It also provides individuals with MS the opportunity to make informed decisions about their lifestyle and manage their symptoms more effectively. However, it’s important to note that the study demonstrates a correlation between changes in activity and disease progression, not necessarily a causation. It’s possible that other factors, such as worsening symptoms or changes in medication, could contribute to both reduced activity and disease progression. Further research is needed to determine whether increasing activity levels can actually sluggish down or prevent MS progression.
The study’s limitations also include the fact that it was conducted on a specific population of individuals with MS, and the findings may not be generalizable to all people with the condition. The study relied on self-reported disability assessments, which can be subjective. The sample size and demographic details of the study population were not immediately available, which limits the ability to assess the broader applicability of the results.
What’s Next for Wearable Technology in MS Research?
Researchers are planning larger, more comprehensive studies to validate these initial findings and explore the potential of wearable technology for personalized MS management. These studies will likely involve a more diverse population of individuals with MS and will incorporate more objective measures of disability progression. The National MS Society is actively supporting research in this area, recognizing the potential of wearable devices to transform MS care. Future research may also focus on developing algorithms that can predict individual risk of progression based on wearable sensor data, allowing for more targeted interventions. The integration of data from multiple wearable sensors, including activity trackers and brain imaging devices, could provide an even more comprehensive picture of disease activity and progression.
the goal is to empower individuals with MS to take a more active role in managing their health and to provide clinicians with the tools they need to deliver more effective and personalized care. While wearable technology is not a cure for MS, it represents a promising step forward in our understanding and management of this complex condition.